ICU Medical, Inc. (NASDAQ:ICUI) Stock Position Trimmed by First Eagle Investment Management LLC

First Eagle Investment Management LLC cut its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 41.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,650 shares of the medical instruments supplier's stock after selling 17,250 shares during the period. First Eagle Investment Management LLC owned about 0.10% of ICU Medical worth $3,825,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. State Street Corp increased its stake in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after acquiring an additional 77,506 shares during the period. Geode Capital Management LLC increased its stake in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after acquiring an additional 48,106 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of ICU Medical by 1.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock worth $47,196,000 after acquiring an additional 3,048 shares during the period. Victory Capital Management Inc. grew its position in ICU Medical by 0.5% during the third quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier's stock worth $25,973,000 after buying an additional 687 shares during the period. Finally, Principal Financial Group Inc. grew its position in ICU Medical by 4.1% during the fourth quarter. Principal Financial Group Inc. now owns 132,099 shares of the medical instruments supplier's stock worth $20,498,000 after buying an additional 5,162 shares during the period. 96.10% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

ICU Medical Trading Down 2.1 %

Shares of ICU Medical stock traded down $3.16 during trading hours on Thursday, hitting $148.09. The company's stock had a trading volume of 226,264 shares, compared to its average volume of 255,720. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The business has a fifty day moving average of $156.48 and a 200 day moving average of $164.65. The company has a market capitalization of $3.63 billion, a PE ratio of -32.40 and a beta of 0.73. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 6.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Tuesday. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. Finally, Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.